Fate Therapeutics (FATE) Long-Term Debt Repayments (2013 - 2019)

Fate Therapeutics' Long-Term Debt Repayments history runs 6 years deep, the most recent figure standing at $14.0 million for Q4 2019.

• Quarterly Long-Term Debt Repayments changed N/A year-over-year to $14.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $22.7 million (changed N/A YoY) and the FY2019 annual result came in at $15.0 million, changed N/A from the prior year.
• Long-Term Debt Repayments was $14.0 million for Q4 2019 at Fate Therapeutics, up from $6.7 million in the prior quarter.
• Across five years, Long-Term Debt Repayments topped out at $14.0 million in Q4 2019 and bottomed at $600000.0 in Q3 2015.
• A 4-year average of $3.4 million and a median of $1.9 million in 2016 frame the typical range for Long-Term Debt Repayments.
• Annual changes were most pronounced in 2015 — Long-Term Debt Repayments decreased 20.0% — and 2017, when it jumped 253.11%.
• Fate Therapeutics' Long-Term Debt Repayments stood at $935000.0 in 2015, then jumped by 111.23% to $2.0 million in 2016, then soared by 239.7% to $6.7 million in 2017, then jumped by 108.67% to $14.0 million in 2019.
• Business Quant data shows FATE's Long-Term Debt Repayments at $14.0 million in Q4 2019, $6.7 million in Q3 2017, and $2.0 million in Q2 2017.